INDOUS vs KOTARISUG: Stock Comparison
KOTARISUG is the larger company by market capitalisation. INDO US BIOTECH shows a higher ROE, a higher ROCE and a higher net margin, while KOTARISUG shows faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
INDOUS leads 6; KOTARISUG leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | INDOUS | KOTARISUG |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Other Agricultural Products | Sugar |
Price
| Metric | INDOUS | KOTARISUG |
|---|---|---|
| Live Price | ₹78.29 | ₹33.79 |
| Day Change | 0.06% | -4.14% |
| Volume | 2,095 | 7.88 L |
| 52-Week High | ₹159 | ₹39.94 |
| 52-Week Low | ₹70 | ₹22.5 |
| Distance from 52W High | -50.76% | -15.4% |
Valuation
| Metric | INDOUS | KOTARISUG |
|---|---|---|
| Market Cap | ₹160 Cr | ₹232 Cr |
| P/E Ratio | 0x | 0x |
| P/B Ratio | 0x | 0x |
| EPS | ₹1.51 | ₹0.01 |
| Book Value | ₹46.15 | ₹35.67 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | INDOUS | KOTARISUG |
|---|---|---|
| Revenue Growth (TTM YoY) | -22% | 16.4% |
| EPS Growth (TTM YoY) | -47.3% | 0% |
| Qtr Sales Growth | 26.75% | 98.81% |
| Qtr Profit Growth | 54.05% | -87.37% |
Profitability & Leverage
| Metric | INDOUS | KOTARISUG |
|---|---|---|
| ROE | 14.18% | 2.24% |
| ROCE | 12.34% | 0.51% |
| Net Margin | 11.88% | -0.1% |
| Operating Margin | 14.64% | 0.75% |
| Debt to Equity | 0.4x | 0.24x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | INDOUS | KOTARISUG |
|---|---|---|
| Promoter Holding | 68.29% | 73.53% |
| FII Holding | 0.01%▼ 0.17 pp | 0.15%▼ 0.01 pp |
| DII Holding | — | 0.49% |
| Public Holding | 31.7%▲ 0.17 pp | 25.81%▲ 0.01 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDO US BIOTECH and KOTARISUG.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.